Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and Healthcare-Associated Infections
- PMID: 38781679
- PMCID: PMC11138981
- DOI: 10.3201/eid3006.231338
Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and Healthcare-Associated Infections
Abstract
Antimicrobial resistance in healthcare-associated bacterial pathogens and the infections they cause are major public health threats affecting nearly all healthcare facilities. Antimicrobial-resistant bacterial infections can occur when colonizing pathogenic bacteria that normally make up a small fraction of the human microbiota increase in number in response to clinical perturbations. Such infections are especially likely when pathogens are resistant to the collateral effects of antimicrobial agents that disrupt the human microbiome, resulting in loss of colonization resistance, a key host defense. Pathogen reduction is an emerging strategy to prevent transmission of, and infection with, antimicrobial-resistant healthcare-associated pathogens. We describe the basis for pathogen reduction as an overall prevention strategy, the evidence for its effectiveness, and the role of the human microbiome in colonization resistance that also reduces the risk for infection once colonized. In addition, we explore ideal attributes of current and future pathogen-reducing approaches.
Keywords: Pathogen reduction; antimicrobial resistance; bacteria; decolonization; healthcare-associated infection; human microbiome; patient safety; transmission prevention.
Figures

Similar articles
-
Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions.Curr Opin Infect Dis. 2020 Dec;33(6):458-463. doi: 10.1097/QCO.0000000000000694. Curr Opin Infect Dis. 2020. PMID: 33074997 Review.
-
Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2).Antimicrob Resist Infect Control. 2019 May 22;8:83. doi: 10.1186/s13756-019-0538-y. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31139366 Free PMC article.
-
Antimicrobial-resistant bacteria in long-term care facilities: infection control considerations.J Am Med Dir Assoc. 2003 May-Jun;4(3 Suppl):S110-4. doi: 10.1097/01.JAM.0000066025.56717.01. J Am Med Dir Assoc. 2003. PMID: 12854983 Review. No abstract available.
-
Controlling healthcare-associated infections: the role of infection control and antimicrobial use practices.Semin Pediatr Infect Dis. 2004 Jan;15(1):30-40. doi: 10.1053/j.spid.2004.01.001. Semin Pediatr Infect Dis. 2004. PMID: 15175993 Review.
-
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011. doi: 10.1086/591861. Infect Control Hosp Epidemiol. 2008. PMID: 18947320
Cited by
-
Protein-based nanoparticles for antimicrobial and cancer therapy: implications for public health.RSC Adv. 2025 May 8;15(19):14966-15016. doi: 10.1039/d5ra01427a. eCollection 2025 May 6. RSC Adv. 2025. PMID: 40343307 Free PMC article. Review.
-
Antimicrobial resistance at a crossroads: the cost of inaction.Lancet. 2024 Sep 21;404(10458):1083-1085. doi: 10.1016/S0140-6736(24)01705-7. Epub 2024 Sep 9. Lancet. 2024. PMID: 39265589 Free PMC article. No abstract available.
-
Associations between total protein, globulin, and nasal Methicillin-Resistant Staphylococcus aureus (MRSA) colonization in US adults: results from the national health and nutrition examination survey 2001-2004.Front Immunol. 2025 May 30;16:1585718. doi: 10.3389/fimmu.2025.1585718. eCollection 2025. Front Immunol. 2025. PMID: 40519902 Free PMC article.
-
Ethical bioprospecting and microbial assessments for sustainable solutions to the AMR crisis.IUBMB Life. 2025 Jan;77(1):e2931. doi: 10.1002/iub.2931. IUBMB Life. 2025. PMID: 39718471 Free PMC article. Review.
-
Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysis.Open Forum Infect Dis. 2025 Jul 2;12(7):ofaf365. doi: 10.1093/ofid/ofaf365. eCollection 2025 Jul. Open Forum Infect Dis. 2025. PMID: 40689244 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. [cited 2023 Jul 20]. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-re...
-
- Centers for Disease Control and Prevention. COVID-19 U.S. impact on antimicrobial resistance: 2022. special report [cited 2023 Jul 20]. https://www.cdc.gov/drugresistance/pdf/covid19-impact-report-508.pdf
-
- Shimasaki T, Seekatz A, Bassis C, Rhee Y, Yelin RD, Fogg L, et al. ; Centers for Disease Control and Prevention Epicenters Program. Increased relative abundance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae within the gut microbiota is associated with risk of bloodstream infection in long-term acute care hospital patients. Clin Infect Dis. 2019;68:2053–9. 10.1093/cid/ciy796 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical